Scientific Sessions 2025  /  Approved and Novel Therapies for the Management of Obstructive and Nonobstructive HCM  /  CMIs in Obstructive HCM: Exploring Sequoia trees with Valor while enjoying Maple syrup
Logo

American Heart Association

  73
  0

Final ID:

CMIs in Obstructive HCM: Exploring Sequoia trees with Valor while enjoying Maple syrup

  • Saberi, Sara  ( University of Michigan , Ann Arbor , Michigan , United States )
    • Author Disclosures:
    Sara Saberi: DO have relevant financial relationships ; Consultant:Cytokinetics, Inc:Active (exists now) ; Research Funding (PI or named investigator):Edgewise:Expected (by end of conference) ; Research Funding (PI or named investigator):Novartis:Past (completed) ; Research Funding (PI or named investigator):Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics, Inc:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Approved and Novel Therapies for the Management of Obstructive and Nonobstructive HCM

Friday, 11/07/2025 , 12:45PM - 02:30PM

Cardiovascular Seminar

More abstracts on this topic:
More (Aerobic) Power to the People

Macnamara James

Invasive Therapies for Obstructive HCM: A shave, a tuck or a squirt?

Smedira Nicholas

More abstracts from these authors:
Discussant: MAPLE-HCM Responder Analysis

Hegde Sheila, Saberi Sara

Is it safe for my patient with genetic cardiomyopathy to exercise?

Lampert Rachel, Ackerman Michael, Saberi Sara, Day Sharlene

You have to be authorized to contact abstract author. Please, Login
Not Available